Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risperidone stimulates food intake and induces body weight gain via the hypothalamic arcuate nucleus 5‐HT2c receptor—NPY pathway
Xiaoqin Wan, Fan Zeng, Xu‐Feng Huang, et al.
CNS Neuroscience & Therapeutics (2019) Vol. 26, Iss. 5, pp. 558-566
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Autophagy and apoptosis cascade: which is more prominent in neuronal death?
Rohan Gupta, Rashmi K. Ambasta, Pravir Kumar
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 24, pp. 8001-8047
Open Access | Times Cited: 101
Understanding the Effects of Antipsychotics on Appetite Control
Sayani Mukherjee, Silje Skrede, Edward Milbank, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 35
Comparison of gut microbiome profile in patients with schizophrenia and healthy controls - A plausible non-invasive biomarker?
Kuppan Gokulakrishnan, Joyappa Nikhil, Biju Viswanath, et al.
Journal of Psychiatric Research (2023) Vol. 162, pp. 140-149
Closed Access | Times Cited: 17
Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review
Marco Solmi, Alessandro Miola, Federico Capone, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 10, pp. 1249-1269
Closed Access | Times Cited: 6
Mechanism and treatments of antipsychotic-induced weight gain
Wujie Ye, Jingyu Xing, Zekai Yu, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 6, pp. 423-433
Closed Access | Times Cited: 16
Dopamine receptor D2 (DRD2) TaqIA gene polymorphism and acute risperidone-induced changes in body weight, plasma glucose and lipid profile
H.S.A. Olasore, Joseph O Faleti, Taiwo Opekitan Afe, et al.
Schizophrenia Research (2025) Vol. 277, pp. 171-176
Closed Access
Predictive Role of Serotonin Receptor (5HTR2A) and Dopamine Receptor (DRD2) gene polymorphisms in risperidone-induced weight gain and hyperprolactinemia in patients with schizophrenia
Alladi Charanraj Goud, Ravi Philip Rajkumar, Deepak Gopal Shewade, et al.
European Journal of Clinical Pharmacology (2025)
Closed Access
Central 5-HTR2C in the Control of Metabolic Homeostasis
Ting Yao, Jiehui He, Zhicheng Cui, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 20
Updated Role of Neuropeptide Y in Nicotine-Induced Endothelial Dysfunction and Atherosclerosis
Yan-li Zheng, Wan-da Wang, Meimei Li, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 18
The role of hypothalamic endoplasmic reticulum stress in schizophrenia and antipsychotic-induced weight gain: A narrative review
Ruqin Zhou, Meng Xiao He, Jun Fan, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 12
The role of the gut microbiome in weight-gain in schizophrenia patients treated with atypical antipsychotics: Evidence based on altered composition and function in a cross-sectional study
Xinyu Fang, Chunying Gao, Weifeng Wu, et al.
Psychiatry Research (2023) Vol. 328, pp. 115463-115463
Closed Access | Times Cited: 6
G protein‐coupled receptor interactions and modification of signalling involving the ghrelin receptor, GHSR1a
Mitchell Ringuet, John B. Furness, Sebastian G. B. Furness
Journal of Neuroendocrinology (2021) Vol. 34, Iss. 9
Open Access | Times Cited: 13
Neonatal Serotonin Depletion Induces Hyperactivity and Anxiolytic-like Sex-Dependent Effects in Adult Rats
Verónica Trujillo, Evandro Valentim‐Lima, Rodrigo Mencalha, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 3, pp. 1036-1051
Closed Access | Times Cited: 14
L-serine improves lipid profile, performance, carcass weight and intestinal parameters in feed restricted broiler chickens during the hot-dry season
Ngozi Ejum Ogbuagu, Joseph Olusegun Ayo, Tagang Aluwong, et al.
Tropical Animal Health and Production (2022) Vol. 54, Iss. 5
Closed Access | Times Cited: 6
Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
Yuying Qiu, Yeqing Dong, Wei Sun, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 3
Novel Insights from Clinical Practice: Xia-Gibbs Syndrome with Pes Cavus, Conjunctival Melanosis, and Eye Asymmetry due to a de novo AHDC1 Gene Variant – A Case Report and a Brief Review of the Literature
Margherita Baga, Ivan Ivanovski, Gianluca Contrò, et al.
Molecular Syndromology (2023) Vol. 15, Iss. 1, pp. 63-70
Closed Access | Times Cited: 3
UBE3A and transsynaptic complex NRXN1-CBLN1-GluD1 in a hypothalamic VMHvl-arcuate feedback circuit regulates aggression
Yi Nong, David C. Stoppel, Mark Johnson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Hypothalamic TRH Mediates Anorectic Effects of Serotonin in Rats
Jorge L. Chávez, Viridiana Alcántara‐Alonso, Cinthia García-Luna, et al.
eNeuro (2022) Vol. 9, Iss. 3, pp. ENEURO.0077-22.2022
Open Access | Times Cited: 4
Effect of risperidone on serum IL-6 levels in individuals with schizophrenia: a systematic review and meta-analysis
Miguel Ángel Ramos-Méndez, Carlos Alfonso Tovilla‐Zárate, Isela Esther Juárez‐Rojop, et al.
International Journal of Psychiatry in Clinical Practice (2022) Vol. 27, Iss. 2, pp. 171-178
Closed Access | Times Cited: 4
CB1/5-HT/GABA interactions and food intake regulation
Rodrigo Erick Escartín-Pérez, Juan Manuel Mancilla Díaz, Felipe Cortés Salazar, et al.
Progress in brain research (2021), pp. 177-196
Closed Access | Times Cited: 5
Metabolic Side Effects of Risperidone in Pediatric Patients with Neurological Disorders: A Prospective Cohort Study
Jawza F. Alsabhan, Nouf Backer Al Backer, Fatimah M. Hassan, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5565-5565
Open Access
Insights into risk factors of the Metabolic Dysfunction-Associated Steatotic Liver Disease development among patients with schizophrenia
Jakub Rogalski, Oliwia Gawlik-Kotelnicka, Tomasz Tomczak
Current Problems of Psychiatry (2024) Vol. 25, pp. 226-238
Open Access
Risperidone upregulates the expression of adhesion molecules VCAM-I, and P-selectin in high-fat diet-induced obese mice
Tabassum Akter, Md. Monirul Islam, Khadiza Begum, et al.
Journal of Affective Disorders Reports (2023) Vol. 13, pp. 100583-100583
Open Access | Times Cited: 1
Increased Interleukins: Effect of Risperidone in Individuals with Schizophrenia—a Systematic Review
Miguel Ángel Ramos-Méndez, Carlos Alfonso Tovilla‐Zárate, Isela Esther Juárez‐Rojop, et al.
SN Comprehensive Clinical Medicine (2023) Vol. 5, Iss. 1
Closed Access | Times Cited: 1
Short-term treatment with risperidone ameliorated 1,2-diacetylbenzene-induced liver dysfunction
Hai Duc Nguyen, Won Hee Jo, Ngoc Hoang, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110687-110687
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top